Login / Signup

Corticosteroid-dependent immune checkpoint inhibitor-induced enterocolitis treated with vedolizumab: a case report.

Da-Long WanChen HuQing-Hong KeTanyang ZhouLinxiang RuanHui TangYan Shen
Published in: Journal of gastrointestinal oncology (2024)
This report illustrates the valuable role of vedolizumab in treating ICI-induced enterocolitis that is refractory to corticosteroid treatment.
Keyphrases
  • high glucose
  • diabetic rats
  • ulcerative colitis
  • patients with inflammatory bowel disease
  • oxidative stress
  • endothelial cells
  • newly diagnosed